Omega-3 and cognitive function: what the scientific literature indicates
Omega-3 fatty acids, specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), are essential nutrients that the human body cannot produce in adequate quantities. The brain is particularly dependent on these nutrients — DHA constitutes approximately part of the fatty acids in neuronal membranes and is crucial for brain structure and function.
Epidemiological evidence
The study by Morris et al. (2015) demonstrated that individuals with higher omega-3 intake, as part of the MIND Diet, showed 53% slower cognitive decline over 4.5 years. Other studies corroborate these findings:
- Yurko-Mauro et al. (2010): Supplementation with 900mg/day DHA for 24 weeks improved episodic and working memory in adults with mild cognitive complaints
- Tan et al. (2012): Lower erythrocyte DHA levels were associated with smaller total brain volume and greater white matter lesion accumulation
- Zhang et al. (2016): Meta-analysis of 21 studies showed higher fish consumption reduced dementia risk by 36%
Neuroprotective mechanisms of omega-3
1. Membrane integrity: DHA is a structural component of neuronal membranes, maintaining fluidity and facilitating synaptic transmission.
2. Neuroinflammation resolution: EPA and DHA are precursors of resolvins and protectins — molecules that actively resolve inflammatory processes in the brain.
3. Neurogenesis: DHA stimulates BDNF production, essential for new neuron and synapse growth, especially in the hippocampus (memory center).
4. Cerebral vascular protection: EPA reduces triglycerides, improves endothelial function, and reduces platelet aggregation, protecting cerebral microvessels.
5. Epigenetic modulation: Omega-3 influences expression of genes related to inflammation and neuroprotection.
Food sources: bioavailability ranking
The richest and most bioavailable EPA + DHA sources:
- Wild salmon: 1.5-2.0g per 100g (richest source)
- Sardines: 1.2-1.5g per 100g (excellent cost-benefit)
- Mackerel: 1.0-1.3g per 100g
- Anchovies: 0.9-1.1g per 100g
- Trout: 0.8-1.0g per 100g
Plant sources (ALA — limited conversion):
- Flaxseed, chia, walnuts provide ALA, but conversion to EPA is only 5-10% and to DHA 2-5%
- Vegetarians/vegans should consider algae-derived DHA supplementation
Dosage and supplementation: what evidence recommends
General maintenance: 250-500mg EPA+DHA/day (equivalent to 2-3 servings fatty fish/week)
Cognitive optimization: 1-2g EPA+DHA/day, with ratio depending on goal:
- Anti-inflammatory focus: more EPA (e.g., 1200mg EPA + 600mg DHA)
- Neuroprotective/memory focus: more DHA (e.g., 600mg EPA + 1200mg DHA)
Monitoring: Omega-3 Index
The Omega-3 Index measures the percentage of EPA+DHA in erythrocyte membranes:
- <4%: Risk zone (severe deficit)
- 4-8%: Suboptimal (most Western population)
- >8%: Optimal (associated with lower cardiovascular and cognitive risk)
- Ideal target: 8-12%
Supplement quality: what to check
Not all omega-3 supplements are equal. Quality criteria:
- Form: Re-esterified triglyceride (rTG) > natural triglyceride > ethyl ester
- Purity: IFOS (International Fish Oil Standards) 5-star certification
- Freshness: TOTOX value <26 (oxidation indicator)
- Concentration: Avoid capsules with <50% EPA+DHA
Conclusion
Omega-3 isn't just another "generic" supplement — it's a nutrient with specific structural and functional roles in the brain. Evidence supports adequate intake through both food and supplementation for cognitive function maintenance, neuroprotection, and inflammatory control. Monitoring via Omega-3 Index enables dose individualization and ensures the investment generates real biological results.
Omega-3 protocol personalization is one of the differentiators I apply in my neuronutrition clinical practice.
Scientific References
Murilo Toscano · CRN-6 26497 · About the author ·
